[Serous otitis media].
D000233:Adenoidectomy; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004322:Drainage; D034381:Hearing Loss / Q000209:etiology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008876:Middle Ear Ventilation / Q000009:adverse effects / Q000295:instrumentation; D014663:Nasal Decongestants / Q000627:therapeutic use; D010033:Otitis Media / Q000503:physiopathology; D010034:Otitis Media with Effusion / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D012008:Recurrence; D012189:Retrospective Studies
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants
Otitis media serosa.